| 产品详情 |
| Edit |   |
|---|
| Product Name | Des-pyrazinecarboxaldehyde Bortezomib |
|---|
| Description | Des-pyrazinecarboxaldehyde Bortezomib is the intermediate and impurity for Bortezomib (B675700), which is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. Molecular Formula: C14H23BN2O3 Molecular Weight: 278.16000000000003 |
|---|
| Size | 10mg, 25mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 446160 |
|---|
| Price | |
|---|
| Order / More Info | Des-pyrazinecarboxaldehyde Bortezomib from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|